El-Adawi Hala, Deng Lili, Tramontano Anthony, Smith Steven, Mascareno Eduardo, Ganguly Kalyan, Castillo Ricardo, El-Sherif Nabil
New York Harbor VA Healthcare System, Brooklyn Campus, Brooklyn, NY 11209, USA.
Cardiovasc Res. 2003 Jan;57(1):129-38. doi: 10.1016/s0008-6363(02)00614-4.
Recently, the Janus kinase/signal transducer and activator of transcription (JAK-STAT) signaling pathway was found to be prominently associated with activation of the autocrine loop of the heart tissue-localized renin angiotensin system (RAS). We investigated if the JAK-STAT pathway is activated in the post-myocardial infarction (MI) non-ischemic myocardium (NIM), destined to undergo remodeling and whether blockade of the pathway in vivo can modify early post-MI remodeling.
We investigated the time course of tyrosine phosphorylation of JAK-STAT and gp130 proteins in the NIM of post-MI rat heart as well as the binding activity of STAT proteins to the St-domain of the angiotensinogen gene promoter. We further compared the effects of in vivo blockade of RAS by the AT(1) receptor (AT(1)R) blocker losartan with the in vivo blockade of JAK-STAT pathway by the specific JAK2 blocker tyrphostin AG490 on certain aspects of early post-MI remodeling.
We showed that JAK2, STATs 1, 3, 5a and 6 and gp130 proteins are tyrosine phosphorylated as early as 5-30 min post-MI and that STATs 1, 3, and 5a remain activated up to 7 days post-MI. Gel mobility shift assay showed a strong binding activity of STAT proteins to the St-domain of angiotensinogen gene promoter in 1-day post-MI NIM. The binding was significantly reduced in rat hearts previously treated with losartan or tyrphostin AG490. Supershift experiments identified STATs 3 and 5a as specifically interacting with the St-domain. Both AT(1)R and JAK2 blockade resulted in significant amelioration of the increase of protein phosphatase 1 activity and decrease in basal level of p16-phospholamban that may underlie early diastolic dysfunction, as well as partial amelioration of early downregulation of Kv4.2 gene expression that may underlie increased arrhythmogenicity of 3-day post-MI heart. On the other hand, while blockade of AT(1)R significantly ameliorated apoptotic changes in 1-day post-MI border zone, blockade of JAK2 increased apoptosis.
The study provides compelling evidence in favor of the linkage of the JAK-STAT pathway with the angiotensin II autocrine loop and uncovers a mechanism by which selective activation of a set of STAT proteins underlies mobilization of the gene activation program intrinsic to post-MI remodeling. It also suggests that drugs that inhibit JAK-STAT phosphorylation may provide a new approach to modify post-MI remodeling. This needs to be confirmed in long term in vivo studies in the post-MI heart.
最近发现,Janus激酶/信号转导子及转录激活子(JAK-STAT)信号通路与心脏组织局部肾素血管紧张素系统(RAS)自分泌环的激活显著相关。我们研究了JAK-STAT通路在心肌梗死后(MI)非缺血心肌(NIM)中是否被激活,该心肌注定会发生重塑,以及体内阻断该通路是否能改变MI后早期重塑。
我们研究了MI后大鼠心脏NIM中JAK-STAT和gp130蛋白酪氨酸磷酸化的时间进程,以及STAT蛋白与血管紧张素原基因启动子St结构域的结合活性。我们进一步比较了血管紧张素Ⅱ1型受体(AT1R)阻滞剂氯沙坦体内阻断RAS与特异性JAK2阻滞剂 tyrphostin AG490体内阻断JAK-STAT通路对MI后早期重塑某些方面的影响。
我们发现,JAK2、STATs 1、3、5a和6以及gp130蛋白在MI后5 - 30分钟内即被酪氨酸磷酸化,并且STATs 1、3和5a在MI后7天内一直保持激活状态。凝胶迁移率变动分析显示,在MI后1天的NIM中,STAT蛋白与血管紧张素原基因启动子的St结构域有很强的结合活性。在用氯沙坦或tyrphostin AG490预处理的大鼠心脏中,这种结合显著减少。超迁移实验确定STATs 3和5a与St结构域特异性相互作用。AT1R和JAK2阻断均导致蛋白磷酸酶1活性增加及p16-受磷蛋白基础水平降低(这可能是早期舒张功能障碍的基础)得到显著改善,以及Kv4.2基因表达早期下调(这可能是MI后3天心脏致心律失常性增加的基础)得到部分改善。另一方面,虽然阻断AT1R显著改善了MI后1天边缘区的凋亡变化,但阻断JAK2却增加了细胞凋亡。
该研究提供了有力证据支持JAK-STAT通路与血管紧张素Ⅱ自分泌环的联系,并揭示了一种机制,即一组STAT蛋白的选择性激活是MI后重塑固有基因激活程序动员的基础。它还表明,抑制JAK-STAT磷酸化的药物可能为改变MI后重塑提供一种新方法。这需要在MI后心脏的长期体内研究中得到证实。